Skip to content

Enovis ENOV Other Financing

Other Financing at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$69M+297%
ESAB logo
ESABESAB
-$3.44M+25.1%
Artivion logo
ArtivionAORT
-$210K-18.0%
Encompass Health Corporation logo
Encompass Health CorporationEHC
-$11.9M-56.6%
CONMED logo
CONMEDCNMD
$828K+278%
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$0

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's other financing?
Enovis (ENOV) reported other financing of -$1.4M in Q1 2026.
How has Enovis's other financing changed year-over-year?
Enovis's other financing increased by 38.4% year-over-year, from -$2.27M to -$1.4M.
What is the long-term trend for Enovis's other financing?
Over 3 years (2021 to 2025), Enovis's other financing has grown at a -12.5% compound annual growth rate (CAGR), from -$9.87M to -$6.62M.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.